Renal cell carcinoma
Magnetic Resonance Imaging (MRI) scans provide an image of the soft tissues in the body using radio waves and strong magnets. MRI can be used instead of CT if the patient exhibits an allergy to the contrast media administered for the test. Sometimes prior to the MRI scan, an intravenous injection of a contrasting material called gadolinium is given to allow for a more detailed image. Patients on dialysis or those who have renal insufficiency should avoid this contrasting material as it may induce a rare, yet severe, side effect known as nephrogenic systemic fibrosis. A bone scan or brain imaging is not routinely performed unless signs or symptoms suggest potential metastatic involvement of these areas.
MRI scans should also be considered to evaluate tumour extension which has grown in major blood vessels, including the vena cava, in the abdomen. MRI can be used to observe the possible spread of cancer to the brain or spinal cord should the patient present symptoms that suggest this might be the case.
Synthetic MRI
Creating a synthetic contrast weighted image is very quick and the scanner setting parameters can be changed interactively. This is different from acquiring the images directly on the MRI scanner with a pulse sequence where it might take several minutes to get new images with different settings. Synthetic MRI also enables the possibility to create new image contrast weightings after the scan has been completed and the patient has left the hospital. A prospective multi-reader, multi-case, multi-center clinical trial of overall image quality of synthetic MRI compared to conventional MRI in a general neuroimaging population has shown that synthetic MRI is non-inferior to conventional imaging.
Synthetic MRI is based on parametric maps. These maps are generated by using the MR scanner not to acquire an image, but to measure magnetic properties in the tissue.